Regentis Biomaterials RGNT Ratios (2024-2026)

NYSE RGNT
$1.90 +0.05 (+2.70%)
As of: Sep 30, 2026 · 2:27 PM EDT
Reported Financials

Regentis Biomaterials Quarterly Ratios

Periods 3 quarters
Latest Jun 2026

Regentis Biomaterials ratios data for the quarter ended Jun 2026. These financial ratios cover 3 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2024 Dec2025 Jun2026
Efficiency
Assets AverageAssets Avg. 4.05M8.48M
Equity AverageEquity Avg. -18.18M6.21M
Invested CapitalInvested Cap. -36.16M5.94M
Leverage & Solvency
Debt Ratio 10.260.16
Valuation
Price to BookP/B 0.810.26
Enterprise Value -3.56M-6.95M
Market Capitalization 3.82M2.00M

Regentis Biomaterials Ratios API

Pull Regentis Biomaterials's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RGNT&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY